Anavex Life Sciences shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Anavex Life Sciences (AVXL) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Anavex Life Sciences
Tip: Access up to 7 years of quarterly data
All positions including Anavex Life Sciences held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Anavex Life Sciences by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $401k | 45k | 8.90 |
| 2025-03-31 | $417k | 49k | 8.58 |
| 2024-12-31 | $438k | 41k | 10.74 |
| 2024-09-30 | $242k | 43k | 5.68 |
| 2024-06-30 | $175k | 41k | 4.22 |
| 2024-03-31 | $244k | 48k | 5.09 |
| 2023-12-31 | $600k | 64k | 9.31 |
| 2023-09-30 | $420k | 64k | 6.55 |
| 2023-06-30 | $482k | 59k | 8.13 |
| 2023-03-31 | $47k | 4.7k | 9.90 |
| 2022-12-31 | $435k | 44k | 9.90 |
| 2022-06-30 | $403k | 41k | 9.90 |
| 2022-03-31 | $546k | 42k | 13.16 |
| 2021-12-31 | $548k | 33k | 16.45 |
| 2021-03-31 | $367k | 22k | 16.45 |
| 2020-12-31 | $413k | 63k | 6.58 |
| 2020-09-30 | $149k | 20k | 7.58 |
| 2020-06-30 | $0 | 42k | 0.00 |
| 2020-03-31 | $43k | 14k | 3.14 |
| 2019-12-31 | $36k | 14k | 2.56 |
| 2019-09-30 | $44k | 14k | 3.13 |
| 2019-06-30 | $38k | 12k | 3.22 |
| 2018-03-31 | $22k | 7.9k | 2.77 |
| 2017-12-31 | $26k | 8.1k | 3.23 |
| 2017-03-31 | $105k | 18k | 5.75 |